AI assistant
PyroGenesis Inc. — Capital/Financing Update 2026
May 20, 2026
46867_rns_2026-05-20_a99f0cb7-5557-4efd-850f-3e01fa927544.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
These securities have not been, and will not be, registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") or any state securities laws, and may not be offered, sold or delivered within the United States or to, or for the account or benefit of, U.S. persons or persons in the United States except in compliance with an exemption from the registration requirements of the U.S. Securities Act and applicable U.S. state securities laws. This offering document (the "Offering Document") does not constitute an offer to sell or a solicitation of an offer to buy any of the securities offered hereby within the United States or to, or for the benefit of, U.S. persons or persons in the United States. "United States" and "U.S. person" have the meanings ascribed to them in Regulation S under the U.S. Securities Act.
No securities regulatory authority or regulator has assessed the merits of these securities or reviewed this document. Any representation to the contrary is an offence. This offering may not be suitable for you and you should only invest in it if you are willing to risk the loss of your entire investment. In making this investment decision, you should seek the advice of a registered dealer.
OFFERING DOCUMENT UNDER THE LISTED ISSUER FINANCING EXEMPTION
May 19, 2026

PYROGENESIS INC.
What are we offering?
Offering:
PyroGenesis Inc. (the "Company" or "PyroGenesis") is offering 8,825,000 units of the Company (each a "Unit") at a price of $0.34 per Unit for aggregate gross proceeds to the Company of $3,000,500 (the "Offering") on a "bought deal" private placement basis in accordance with the listed issuer financing exemption under Part 5A of National Instrument 45-106 – Prospectus Exemptions ("NI 45-106"), as amended by Coordinated Blanket Order 45-935 – Exemptions from Certain Conditions of the Listed Issuer Financing Exemption (the "Listed Issuer Financing Exemption").
Each Unit consists of one common share of the Company (each a "Unit Share") and one common share purchase warrant (each a "Warrant"). Each Warrant will entitle the holder thereof to acquire, subject to adjustment in accordance with the Warrant Indenture (as defined herein), one common share of the Company (a "Warrant Share") at a price of $0.42 per Warrant Share at any time prior to 5:00 p.m. (Toronto time) on the date that is 36 months following the Closing Date (as defined herein), with the exception of the Warrants to be issued under the Private Placement, which will expire 24 months from the Closing Date. The Warrants will be governed by a warrant indenture (the "Warrant Indenture") to be entered into on or before the Closing Date between the Company and TSX Trust Company, as warrant agent. The Units will be immediately separated into Unit Shares and Warrants upon issuance.
Subject to the rights, privileges, restrictions and conditions attaching to any preferred shares authorized in the future, the rights of the holders of Common Shares, as a class, are equal in all respects and include the right: (i) to vote at any
meeting of shareholders, (ii) to receive, as and when declared by the directors of the Company, any dividends payable on such dates, for such amounts and at such place or places as the Board may from time to time determine, and (iii) to receive the remaining property of the Company on liquidation or dissolution.
The Offering is being made pursuant to an underwriting agreement to be entered into between the Underwriter (as defined herein) and the Company on or before the Closing Date (as defined herein). The Units offered under the Offering will be offered and sold to purchasers by way of a “bought deal” private placement in each of the provinces of Canada pursuant to the Listed Issuer Financing Exemption, and will not be subject to a hold period pursuant to applicable Canadian securities laws.
The Underwriter will endeavour to arrange for substituted purchasers of the Units offered under the Offering with the effect that such substituted purchasers will be the initial purchasers of the Units offered under the Offering.
Offering Price:
$0.34 per Unit (the “Offering Price”).
Offering Amount:
8,825,000 Units for gross proceeds of $3,000,500 (10,148,750 Units for gross proceeds of $3,450,575 if the Underwriter” Option (as defined herein) is exercised in full).
The Offering is a “bought deal” private placement and, as a result, is not subject to a minimum.
Closing Date:
The Offering is expected to close on or about June 3, 2026 (the “Closing Date”), or on such date as may be agreed upon between the Company and the Underwriter, subject to approval of the Toronto Stock Exchange (“TSX”).
Underwriter:
Research Capital Corporation (“RCC”) will act as sole underwriter and sole bookrunner pursuant to an underwriting agreement to be entered into with the Company in connection with the Offering (the “Underwriter”) The Underwriter shall purchase (with the right to arrange for substitute purchasers) from the Company, on a “bought deal” private placement basis, all of the Units.
Underwriter’s Option:
The Company has granted the Underwriter’s an option, exercisable in whole or in part at any time up to 48 hours prior to the Closing Date, to sell up to an additional 1,323,750 Units, on the same terms for additional gross proceeds of up to $450,075 (the “Underwriter’s Option”).
Concurrent Private Placement:
The Offering is being conducted concurrently with a non-brokered private placement of up to $2 million of Units at the Offering Price (the “Private Placement”). The Units issued pursuant to the Private Placement are being issued pursuant to available prospectus exemptions, other than the Listed Issuer Financing Exemption, in accordance with NI 45-106. The Private Placement will close concurrently with the Offering.
Exchange:
The outstanding Common Shares are listed and admitted for trading on the TSX under the symbol “PYR”, the OTCQX in the U.S. under “PYRGF”, and on the Frankfurt Stock Exchange under the symbol “8PY1”.
2
The Company will apply to list the Unit Shares and the Warrant Shares on the TSX, which listing will be subject to the approval of the TSX in accordance with its applicable listing requirements.
There is no market through which the Warrants may be sold and purchasers may not be able to resell the Warrants that are purchased under the Offering. In addition, the Warrants will not be listed for trading on the TSX or any other stock exchange following the Closing Date. This may affect the pricing of the Warrants in the secondary market, the transparency and availability of trading prices, the liquidity of the Warrants and the extent of issuer regulation.
Last Closing Price:
On May 19, 2026, the closing price of the Common Shares on the TSX was $0.39.
The Company is conducting a listed issuer financing under section 5A.2 of National Instrument 45-106 - Prospectus Exemptions. In connection with this Offering, the Company represents the following is true:
- The Company has active operations and its principal asset is not cash, cash equivalents or its exchange listing.
- The Company has filed all periodic and timely disclosure documents that it is required to have filed.
- The Company is relying on the exemptions in Coordinated Blanket Order 45-935 Exemptions from Certain Conditions of the Listed Issuer Financing Exemption (the "Order") and is qualified to distribute securities in reliance on the exemptions included in the Order.
- The total dollar amount of this Offering, in combination with the dollar amount of all other offerings made under the Listed Issuer Financing Exemption in the 12 months immediately before the date of the news release announcing this Offering, will not exceed the greater of $25,000,000.
- The Company will not close this Offering unless the issuer reasonably believes that it has raised sufficient funds to meet its business objectives and liquidity requirements for a period of 12 months following the distribution.
- The Company will not allocate the available funds from this Offering to an acquisition that is a significant acquisition or restructuring transaction under securities law or to any other transaction for which the Company seeks security holder approval.
Unless otherwise indicated, all references to “$”, “C$” or “dollars” in this Offering Document refer to Canadian dollars.
4
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS
This Offering Document contains certain information and statements that may constitute “forward-looking information” within the meaning of Canadian securities laws and “forward-looking statements” within the meaning of applicable United States securities laws, which the Company refers to in this Offering Document as “forward-looking statements”. These statements reflect management’s current expectations related to future events or its future results, performance, achievements, business prospects or opportunities, products and services development, and future trends affecting the Company. All such statements, other than statements of historical fact, are forward-looking statements. Forward-looking statements are often, but not always, identified by the use of words such as “seek”, “anticipate”, “plan”, “continue”, “estimate”, “expect”, “may”, “will”, “project”, “predict”, “potential”, “targeting”, “intend”, “could”, “might”, “would”, “should”, “believe”, “objective”, “ongoing”, “imply”, “assumes”, “goal”, “likely” or the negative of these words or other variations or synonyms of these words or comparable terminology and similar expressions. Forward-looking statements contained or incorporated by reference in this Offering Document include, but are not limited to, statements pertaining to the closing of the Offering and the Private Placement and the timing thereof; the expected use of the Company’s available funds and proceeds from the Offering and the Private Placement; and the Company’s business objectives.
Undue reliance should not be placed on forward-looking statements. Actual results and developments are likely to differ, and may differ materially, from those anticipated by the Company and expressed or implied by the forward-looking statements contained in this Offering Document. Forward-looking statements are based on a number of assumptions and risks that may prove to be incorrect, including, without limitation, assumptions about: the Company’s business strategies, strategic objectives and growth strategy; the Company’s current and future capital resources and the need for additional financing; the Company’s ability to increase sales from new and existing customers, and the results of the successful completion of the Company’s current projects; management’s expectation that the Company will achieve growth and profitability; the Company’s overall financial performance; the Company continuing to maintain sufficient and effective production and research and development; there being no significant reduction in the availability of qualified and cost-effective human resources; there will be adequate liquidity available to the Company to carry out its operations; and the Company’s ability to obtain and retain key personnel.
Many factors could cause the Company’s actual results, level of activity, performance, achievements, future events or developments to differ materially from those expressed or implied by forward-looking statements, including, without limitation, the following risk factors: operating income (loss) and negative operating cash flow risk; actual financial position and results of operations risk; revenue risk; concentration risk; technology development and manufacturing capability; additional financing and dilution; reliance on third party suppliers, service providers, distributors and manufacturers; manufacturing facility; sales cycle and fixed price contracts; reliance on technology; changes to contracts; foreign exchange exposure; competition; management and key personnel; implementation of a strategic plan; adverse decisions of sovereign governments; international operations; governmental regulation; government-funded defense and security programs; environmental liability; product liability and other lawsuits; information systems disruptions; security breaches; public health crises; litigation; trade secrets; risks related to acquiring companies; global economic uncertainty; inability to renew leases; financial reporting and other public issuer requirements; influence of the significant shareholders; joint venture/partnership arrangements; limited control over the Company’s operations; change in tax laws; forward-looking information; credit facilities; potential volatility of Common Share price; market liquidity; dividends to shareholders; impact of future sales by existing shareholders; working capital and future issuances; securities or industry analysts; and those risks set out in the Company’s public documents filed on SEDAR+ at www.sedarplus.com. For more information on the Company and the risks and challenges of its business, investors should review the Company’s annual filings that are available at www.sedarplus.com.
There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those expressly or impliedly expected or estimated in such statements. Securityholders and potential investors should not place undue reliance on forward-looking statements as the plans, assumptions, intentions or expectations upon which they are based might not occur. The forward-looking statements contained or incorporated by reference in this Offering Document are expressly qualified by this cautionary statement. Forward-looking statements contained in this Offering Document describe the Company's expectations, estimates and opinions as of the date hereof and, accordingly, are subject to change after such date. The Company does not undertake or assume any obligation to update or revise any forward-looking statements for any reason, except as required by applicable securities laws.
SUMMARY DESCRIPTION OF BUSINESS
What is our business?
PyroGenesis develops technology to transform high temperature processes for heavy industry and defense, which can result in improved operational efficiencies, higher product quality, increased output, lower cost, lower emissions, simplified logistics, reduced carbon footprint, and safer working/living environments. Most of the technologies stem from the Company's core expertise in plasma.
PyroGenesis leverages 35 years of plasma technology leadership to deliver advanced engineering solutions to energy, propulsion, destruction, process heating, emissions, and materials development challenges across heavy industry and defense. Its customers include global leaders in aluminum, aerospace, steel, iron ore, utilities, environmental services, military, and government.
The Company's technology solutions are categorized across three business verticals:
- Energy Transition:
Plasma-based fuel switching solutions to help heavy industry electrify high-temperature processes, modify the energy mix, and lower emissions.
- Materials Production:
Development of chemical-free material production systems, and the production of in-demand materials, for manufacturers.
- Waste Processing:
Safe, emission-free destruction, remediation, and valorization of industrial, chemical, agricultural, and municipal solid waste, on land and at sea.
Within each business vertical the Company offers a wide array of technology solutions at different stages, from early-stage R&D to pre-commercial pilots, to commercial-ready and fully commercialized.
A non-comprehensive list of products and services include:
- Plasma torch systems, used for, among other things, replacing conventional fossil-fuel burners in high temperature industrial applications, such as metal melting, heating, and holding furnaces and various heated process steps for sectors such as aluminum and steel;
5
- Waste processing systems (for remediation, destruction, and waste-to-energy), offered predominantly to customers in the environmental and defense industries, for the destruction of combustible and organic waste, end-of-life refrigerants, chemical weapons, and plastic industry synthetic compounds such as per- and polyfluoroalkyl substances (PFAS), often referred to as “forever chemicals”;
- Systems for the recovery of aluminum and other metal from “dross” (a waste byproduct generated by primary and secondary metal producers), offered mainly to customers in the mining and metallurgical industries;
- Production of high purity spherical metal powders, which are predominantly offered to customers in the additive manufacturing (also known sometimes as 3D printing) industry;
- Development of processes to produce high purity silicon metals, nano powders and nanowires, offered predominantly to customers in the mining and metallurgical industries as well as those in the battery manufacturing and/or disposal business;
- Systems for upgrading of biogas and landfill gas into renewable natural gas, used in the environmental industry;
- Systems used in the petrochemical and metallurgical industries for the purification of industrial gases, including the extraction of hydrogen from coke oven gas, the purification of natural gas into high purity methane, and the purification of pyrolytic gases;
- Development of a process to produce fumed silica, used in the polymer, cosmetics, and paint industries;
- Installation, commissioning, and start-up services; and
- Internally and externally funded research and development projects.
Recent Developments
On May 14, 2026, the Company announced that it had entered into an out-of-court settlement agreement of its action in the Superior Court of Quebec to order the owner of the property located at 5655 Philippe-Turcot, Montréal, Québec (the “Turcot Facility”), one of the Company’s manufacturing facilities, to convey title of the property under PyroGenesis’ contractual option to purchase. The settlement agreement allows PyroGenesis to acquire the Turcot Facility for a purchase price of $3.1 million, with all parties to the proceedings providing full and final releases as per a signed agreement that has been homologated by the Superior Court of Quebec.
Material Facts
There are no material facts about the securities being distributed that has not been disclosed elsewhere in this Offering Document or in any other document filed by the Company in the 12 months preceding the date of this Offering Document.
What are the business objectives that we expect to accomplish using the available funds?
The Company intends to use a portion of the proceeds raised from the Offering for working capital and advancements of contracts and backlog. There are no significant events which must occur in order to accomplish this business objective.
USE OF AVAILABLE FUNDS
What will our available funds be upon the closing of the Offering?
The net proceeds of the Offering and the funds which will be available to the Company after the Offering are as follows, assuming no Units are sold to purchasers on the President’s List (as defined herein). See the “Fees and Commissions” section below.
| Amount (Assuming the Underwriter’s Option is Not Exercised) | Amount (Assuming the Underwriter’s Option is Exercised in Full) Scenario 1^{(3)} | Amount (Assuming the Underwriter’s Option is Exercised in Full) Scenario 2^{(3)} | ||
|---|---|---|---|---|
| A | Amount to be raised by this Offering | $3,000,500 | $3,450,575 | $3,450,575 |
| B | Selling commissions and fees | $195,032. | $224,287.38 | $224,287.38 |
| C | Estimated Offering costs (e.g. legal, accounting, audit) | $150,000 | $150,000 | $150,000 |
| D | Net proceeds of Offering: D = A – (B + C) | $2,655,467.50 | $3,076,287.62 | $3,076,287.62 |
| E | Estimated working capital as at most recent month end (deficiency)^{(1)} | ($13,500,000) | ($13,500,000) | ($13,500,000) |
| F | Additional sources of funding^{(2)} | $14,500,000 | $14,500,000 | $15,500,000 |
| G | Total available funds: G = D + E + F | $3,655,467.50 | $4,076,287.62 | $5,076,287.62 |
Notes:
(1) The estimated working capital is unaudited based on preliminary results and are subject to customary financial statement procedures by the Company and its auditors.
(2) Includes the proceeds of the concurrent Private Placement, and carry forward of a working capital deficiency. The Company’s working capital deficiency is primarily attributable to the timing of project-related cash inflows and the recognition of current liabilities associated with ongoing operations. The Company expects to fund this deficiency through a combination of: (i) the net proceeds of the Offering; (ii) anticipated cash inflows from existing customer contracts and backlog; (iii) additional sources of financing, including the concurrent private placement and potential future financing initiatives; and (iv) the continued management and deferral of certain current liabilities in the ordinary course of business. Based on the foregoing assumptions, management believes that the Company will have sufficient available funds to meet its business objectives and liquidity requirements for at least 12 months following the completion of the Offering.
(3) Assumes the underwriter’s option is exercised in full. In addition, Scenario 1 includes a concurrent private placement of $1,000,000, whereby Scenario 2 assumes such amount to be $2,000,000.
The Company has a history of negative operating cash flows and is reliant on the continued availability of financing to fund its operating activities. To the extent that the Company has negative operating cash flows in future periods, it will need to deploy a portion of the net proceeds from the sale of the Units and/or any working capital existing at such time to fund such negative cash flow.
The Company’s working capital deficiency improved from approximately $15.4 million at December 31, 2025, to approximately $13.8 million at March 31, 2026. The improvement is derived primarily from the increase in accounts receivable, deposits and prepaid expenses, offset by a decrease in costs and profits in excess of billings on uncompleted contracts and cash. The improvement in working capital deficiency is also attributable to a decrease in billings in excess of costs and profits on uncompleted contracts, convertible debenture, secured loans, and offset by the increase in accounts payable and accrued liabilities.
7
How will we use the available funds?
The Company intends to use the available funds as follows:
| Description of intended use of available funds listed in order of priority | Amount (Assuming the Underwriter’s Option is Not Exercised) | Amount (Assuming the Underwriter’s Option is Exercised in Full) Scenario 1 | Amount (Assuming the Underwriter’s Option is Exercised in Full) Scenario 2 |
|---|---|---|---|
| Working capital and advancements of contracts and backlog | $3,655,467.50 | $4,076,287.62 | $5,076,287.62 |
| Total: Equal to “G” Total Available Funds in Chart Above | $3,655,467.50 | $4,076,287.62 | $5,076,287.62 |
The above noted allocation and anticipated timing represents the Company’s current intentions with respect to its use of proceeds based on current knowledge, planning and expectations of management of the Company. Although the Company intends to expend the proceeds from the Offering as set forth above, there may be circumstances where, for sound business reasons, a reallocation of funds may be deemed prudent or necessary and may vary materially from that set forth above, as the amounts actually allocated and spent will depend on a number of factors, including the Company’s ability to execute on its business plan.
8
How have we used the other funds we have raised in the past 12 months?
| Description of intended use of available funds or proceeds from financings in the past 12 months | Proposed use of proceeds from financings completed in the past 12 months ($) | Use of Funds to Date ($) |
|---|---|---|
| May 12, 2025: Private placement for total gross proceeds of $2,385,000 | Proceeds were intended and used for working capital and general corporate purposes | $2,385,000 |
| October 24, 2025: Private placement for total gross proceeds of $3,500,000 | Proceeds were intended and used for working capital and general corporate purposes | $3,500,000 |
| November 10, 2025: Private placement for total gross proceeds of $822,000 | Proceeds were intended and used for working capital and general corporate purposes | $822,000 |
| December 1, 2025: Private placement for total gross proceeds of $904,083 | Proceeds were intended and used for working capital and general corporate purposes | $904,083 |
| March 26, 2026: Private placement for total gross proceeds of $1,973,449 | Proceeds were intended and used for working capital and general corporate purposes | $1,973,449 |
FEES AND COMMISSIONS
Who are the dealers or finders that we have engaged in connection with this offering, if any, and what are their fees?
| Underwriter: | RCC to act as sole underwriter and sole bookrunner for the Offering. |
|---|---|
| Compensation Type: | Cash commission and Broker Warrants (as defined herein). |
| Cash Commission: | Cash commission equal to 6.5% of the gross proceeds of the Offering (provided that a cash commission equal to 3.25% shall be payable in respect of gross proceeds from Units sold to purchasers identified by the Company (the “President’s List”). |
| Total Cash Commission: | $195,032.50, assuming the Underwriter’s Option is not exercised and that no Units are sold to purchasers on the President’s List. |
| $224,287.38, assuming the Underwriter’s Option is exercised and that no Units are sold to purchasers on the President’s List. | |
| Broker Warrants: | Such number of broker warrants (the “Broker Warrants”) as is equal to 6.5% of the Units sold under the Offering (provided that Broker Warrants equal to 3.25% shall be issuable in respect of Units sold to President’s List. Each Broker Warrant shall be exercisable to acquire one Common Share exercisable at a price of $0.42 for 36 months following the Closing Date. |
Does the Underwriter have a conflict of interest?
To the knowledge of the Company, it is not a “related issuer” or “connected issuer” of or to the Underwriter, as such terms are defined in National Instrument 33-105 - Underwriting Conflicts.
PURCHASERS' RIGHTS
Rights of Action in the Event of a Misrepresentation
If there is a misrepresentation in this Offering Document, you have a right:
(a) to rescind your purchase of these securities with the Company; or
(b) to damages against the Company and may, in certain jurisdictions, have a statutory right to damages from other persons.
These rights are available to you whether or not you relied on the misrepresentation. However, there are various circumstances that limit your rights. In particular, your rights might be limited if you knew of the misrepresentation when you purchased the securities.
If you intend to rely on the rights described in paragraph (a) or (b) above, you must do so within strict time limitations.
You should refer to any applicable provisions of the securities legislation of your province or territory for the particulars of these rights or consult with a legal advisor.
ADDITIONAL INFORMATION
Please refer to Appendix “A” – “Acknowledgements, Covenants, Representations and Warranties of the Purchaser” and Appendix “B” – “Indirect Collection of Personal Information” attached hereto.
Where can you find more information about us?
You can access the Company’s continuous disclosure record under its profile on SEDAR+ at www.sedarplus.com and at the Company’s website at www.pyrogenesis.com.
10
11
CERTIFICATE OF THE COMPANY
May 19, 2026
This Offering Document, together with any document filed under Canadian securities legislation on or after May 19, 2026, contains disclosure of all material facts about the securities being distributed and does not contain a misrepresentation.
(s) P. Peter Pascali
P. Peter Pascali
President and Chief Executive Officer
(s) Andre Mainella
Andre Mainella
Chief Financial Officer
APPENDIX A
ACKNOWLEDGEMENTS, COVENANTS, REPRESENTATIONS AND WARRANTIES OF THE PURCHASER
Each purchaser of Units (each, a “Purchaser”) makes, and is deemed to make, the following acknowledgements, covenants, representations and warranties to the Company and the Underwriter, as at the date hereof, and as of the Closing Date:
(a) the Purchaser is resident in the jurisdiction disclosed to the Underwriter or the Company and the Purchaser was solicited to purchase in such jurisdiction;
(b) the Purchaser has not received, nor has the Purchaser requested, nor does the Purchaser have any need to receive, any prospectus, sales or advertising literature, offering memorandum or any other document (other than an annual or interim report, financial statements or any other document, other than an offering memorandum, the content of which is prescribed by statute or regulation) describing or purporting to describe the business and affairs of the Company which has been prepared for delivery to, and review by, prospective purchasers in order to assist them in making an investment decision in respect of the purchase of Units pursuant to the Offering;
(c) the Purchaser has relied only upon publicly available information relating to the Company and not upon any verbal or written representation as to fact, and the Purchaser acknowledges that the Company has not made any written representations, warranties or covenants in respect of such publicly available information except as set forth in this Offering Document. Without limiting the generality of the foregoing, except as may be provided herein, no person has made any written or oral representation to the Purchaser that any person will re-sell or re-purchase the Units (or the underlying Unit Shares, Warrants or Warrant Shares) or refund any of the purchase price of the Units (or the underlying Unit Shares, Warrants or Warrant Shares), or that the Units will be listed on any exchange or quoted on any quotation and trade reporting system, or that application has been or will be made to list any such security on any exchange or quote the security on any quotation and trade reporting system, and no person has given any undertaking to the Purchaser relating to the future value or price of the Units (or the underlying Unit Shares, Warrants or Warrant Shares);
(d) legal counsel retained by the Company and the Underwriter is acting as counsel to the Company and the Underwriter, respectively, and not as counsel to the Purchaser and the Purchaser may not rely upon such counsel. The Purchaser should obtain independent legal and tax advice as it considers appropriate in connection with the performance of this Offering Document and the transactions contemplated under this Offering Document, and that the Purchaser is not relying on legal or tax advice provided by the Company, the Underwriter or their counsel;
(e) the Purchaser acknowledges that:
a. no securities commission or similar regulatory authority has reviewed or passed on the merits of the Offering;
b. there is no government or other insurance covering the Offering;
c. there are risks associated with the purchase of the Offering;
(f) the Company has advised the Purchaser that the Company is relying on an exemption from the requirements to provide the Purchaser with a prospectus and to sell the Units through a person or company registered to sell securities under applicable securities laws and, as a consequence of acquiring the Units pursuant to this exemption, certain protections, rights and remedies provided by the applicable securities laws, including statutory rights of rescission or damages, will not be available to the Purchaser and the Purchaser may not receive information that would otherwise be required to be given; and
(g) the Purchaser either (A) is not an “insider” of the Company or a “registrar” (each as defined under applicable securities laws of Québec) or (B) has identified itself to the Company as either an “insider” or a “registrar” (each as defined under applicable securities laws of Québec);
(h) if the Purchaser is:
a. a corporation, the Purchaser is duly incorporated and is validly subsisting under the laws of its jurisdiction of incorporation and has all requisite legal and corporate power and authority to subscribe for the Units pursuant to the terms set out in this Offering Document;
b. a partnership, syndicate or other form of unincorporated organization, the Purchaser has the necessary legal capacity and authority to subscribe for the Units pursuant to the terms set out in this Offering Document and has obtained all necessary approvals in respect thereof; or
c. an individual, the Purchaser is of the full age of majority and is legally competent to subscribe for the Units pursuant to the terms set out in this Offering Document;
(i) the subscription for the Units and the completion of the transactions described herein by the Purchaser will not result in any material breach of, or be in conflict with or constitute a material default under, or create a state of facts which, after notice or lapse of time, or both, would constitute a material default under any term or provision of the constating documents, bylaws or resolutions of the Purchaser if the Purchaser is not an individual, the applicable securities laws or any other laws applicable to the Purchaser, any agreement to which the Purchaser is a party, or any judgment, decree, order, statute, rule or regulation applicable to the Purchaser;
(j) the Purchaser is not purchasing the Units with knowledge of any material fact or material change about the Company that has not been generally disclosed and the decision of the Purchaser, to acquire Units has not been made as a result of any oral or written representation as to fact or otherwise made by, or on behalf of, the Company or any other person and is based entirely upon the Offering Document;
(k) the Purchaser is aware that the Units (or the underlying Unit Shares, Warrants or Warrant Shares) have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”) or the securities laws of any state of the United States and that the Units (or the underlying Unit Shares, Warrants or Warrant Shares) may not be offered, sold or otherwise disposed of, directly or indirectly, in the United States, any state or territory of the United States or the District of Columbia, without registration under the U.S. Securities Act and all applicable state securities laws or compliance with the requirements of an exemption from such registration and it acknowledges that the Company has no obligation or present intention of filing a registration statement under the U.S. Securities Act in respect of the sale or resale of the Units (or the underlying Unit Shares, Warrants or Warrant Shares);
(l) if Purchaser is not a “qualified institutional buyer” (as defined in Rule 144A under the U.S. Securities Act, each a “QIB”), then Purchaser (i) acknowledges it has not purchased the Units as a result of any “directed selling efforts” (as defined in Regulation S under the U.S. Securities Act (“Regulation S”)), (ii) is not a “U.S. person” (as defined in Regulation S), and is not purchasing for the account or benefit of a U.S. person or person in the United States, (iii) was not in the United States when it made its investment decision to purchase the Units, (iv) the structure and purchase of the Units is not a scheme to avoid the registration requirements of the U.S. Securities Act or any applicable securities laws of any states of the United States;
(m) if the Purchaser is a QIB, then the Purchaser:
a. is acquiring the Units, for its own account and not on behalf of any other person or for the account of a QIB with respect to which it exercises sole investment discretion and not with
13
a view to any resale, distribution or other disposition of the Units in violation of United States federal or state securities laws;
b. it is not an “affiliate” (as defined in Rule 144 under the U.S. Securities Act) of the Company and is not acting on behalf of an affiliate of the Company;
c. it understands and acknowledges that the Units (and the underlying Unit Shares, Warrants and Warrant Shares) acquired by it in the United States will be considered “restricted securities” within the meaning of Rule 144(a)(3) under the U.S. Securities Act (“Restricted Securities”). To induce the Company to issue the Units to the Purchaser without a U.S. Securities Act restrictive legend, the Purchaser represents, warrants and covenants to the Company as follows (collectively, the “Restricted Security Agreements”): (a) if in the future it decides to offer, sell, pledge, or otherwise transfer, directly or indirectly, any of the Units (or the underlying Unit Shares, Warrants or Warrant Shares) it will do so only: (i) to the Company (though the Company is under no obligation to purchase any such securities) or (ii) outside the United States in accordance with Rule 904 of Regulation S and in compliance with applicable local laws or regulations; (b) it will cause any CDS Clearing and Depository Services Inc. (“CDS”) participant holding such securities, if any, on its behalf, and the beneficial purchaser of such securities, if any, to comply with the Restricted Security Agreements; (c) for so long as such securities, if any, constitute Restricted Securities, it will not deposit any of such securities, if any, into the facilities of the Depository Trust Company, or a successor depository within the United States, or arrange for the registration of any of such securities, if any, with Cede & Co. or any successor thereto; it understands and acknowledges that the Units (or the underlying Unit Shares, Warrants or Warrant Shares) may not, be represented by certificates that bear a U.S. restrictive legend or identified by a restricted CUSIP number in reliance on the acknowledgments, representations and agreements contained herein, including the Restricted Security Agreements set forth above; and
d. it has implemented appropriate internal controls and procedures to ensure compliance with the Restricted Security Agreements;
(n) the funds representing the aggregate subscription funds which will be advanced by the Purchaser to the Company hereunder, as applicable, will not represent proceeds of crime for the purposes of the Proceeds of Crime (Money Laundering) and Terrorist Financing Act (Canada) (the “PCMLTFA”) or for the purposes of the United States Uniting and Strengthening America by Providing Appropriate Tools Required to Intercept and Obstruct Terrorism Act, as may be amended from time to time (the “PATRIOT Act”) and the Purchaser acknowledges that the Company may in the future be required by law to disclose the Purchaser’s name and other information relating to the Purchaser’s subscription of the Units, on a confidential basis, pursuant to the PCMLTFA and the PATRIOT Act, and that, to the best of its knowledge: (i) none of the subscription funds to be provided by the Purchaser (A) have been or will be derived from or related to any activity that is deemed criminal under the laws of Canada, the United States or any other jurisdiction; or (B) are being tendered on behalf of a person who has not been identified to the Purchaser; and (ii) it will promptly notify the Company if the Purchaser discovers that any of such representations ceases to be true, and to provide the Company with appropriate information in connection therewith;
(o) neither the Company, the Underwriter, nor any of their respective directors, employees, officers, affiliates or agents has made any written or oral representations to the Purchaser: (i) that any person will resell or repurchase the Units (or the underlying Unit Shares, Warrants or Warrant Shares); (ii) that any person will refund all or any part of the purchase price of the Units (or the underlying Unit Shares,
14
Warrants or Warrant Shares) acquired by the Purchaser; or (iii) as to the future price or value of the Units (or the underlying Unit Shares, Warrants or Warrant Shares);
(p) if required by applicable securities laws or the Company, the Purchaser will execute, deliver and file or assist the Company in filing such reports, undertakings and other documents with respect to the issue and/or sale of the Units as may be required by any securities commission, stock exchange or other regulatory authority;
(q) the Purchaser has obtained all necessary consents and authorities to enable it to agree to subscribe for Units pursuant to the terms set out in this Offering Document and the Purchaser has otherwise observed all applicable laws, obtained any requisite governmental or other consents, complied with all requisite formalities and paid any issue, transfer or other taxes due in any territory in connection with the purchase of the Units and the Purchaser has not taken any action which will or may result in the Company acting in breach of any regulatory or legal requirements of any territory in connection with the Offering or the Purchaser’s subscription;
(r) the Purchaser is purchasing the Units for investment purposes only and not with a view to resale or distribution; and
(s) the Purchaser acknowledges that certain fees and commissions may be payable by the Company in connection with the Offering.
15
APPENDIX B
INDIRECT COLLECTION OF PERSONAL INFORMATION
By purchasing Units, the purchaser (each a “Purchaser”) acknowledges that the Company and the Underwriter and their respective agents and advisers may each collect, use and disclose its name and other specified personally identifiable information (including its name, jurisdiction of residence, address, telephone number, email address and aggregate value of the Units that it has purchased) (the “Information”), for purposes of (i) meeting legal, regulatory, stock exchange and audit requirements and as otherwise permitted or required by law or regulation, and (ii) issuing ownership statements issued under a direct registration system or other electronic book-entry system, or certificates that may be issued, as applicable, representing the Units to be issued to the Purchaser. The Information may also be disclosed by the Company to: (i) stock exchanges, (ii) revenue or taxing authorities and (iii) any of the other parties involved in the Offering, including legal counsel, and may be included in record books in connection with the Offering. The Purchaser is deemed to be consenting to the disclosure of the Information.
By purchasing Units the Purchaser acknowledges (A) that Information concerning the Purchaser will be disclosed to the relevant Canadian securities regulatory authorities, including the British Columbia Securities Commission, the Alberta Securities Commission, the Ontario Securities Commission and the Autorité des marchés financiers, and may become available to the public in accordance with the requirements of applicable securities and freedom of information laws and the Purchaser consents to the disclosure of the Information; (B) the Information is being collected indirectly by the applicable Canadian securities regulatory authorities under the authority granted to them in securities legislation; and (C) the Information is being collected for the purposes of the administration and enforcement of the applicable Canadian securities legislation; and by purchasing the Units, the Purchaser shall be deemed to have authorized such indirect collection of personal information by the relevant Canadian securities regulatory authorities.
The Purchaser may contact the following public official in the applicable province with respect to questions about the commission’s indirect collection of such Information at the following address, telephone number and email address (if any):
Alberta Securities Commission
Suite 600, 250 - 5th Street SW
Calgary, Alberta T2P 0R4 Telephone: 403 297-6454
Toll free in Canada: 1-877-355-0585
Facsimile: 403-297-6156
Public official contact regarding indirect collection of information: FOIP Coordinator
British Columbia Securities Commission
P.O. Box 10142, Pacific Centre
701 West Georgia Street
Vancouver, British Columbia V7Y 1L2
Inquiries: 604-899-6854
Toll free in Canada: 1-800-373-6393
Facsimile: 604-899-6506
Email: [email protected]
Public official contact regarding indirect collection of information: Privacy Officer
17
The Manitoba Securities Commission
500-400 St. Mary Avenue
Winnipeg, Manitoba R3C 4K5
Telephone: 204-945-2561
Toll Free in Manitoba: 1-800-655-5244
Facsimile: 204-945-0330
Public official contact regarding indirect collection of information: Director
Financial and Consumer Services Commission, New Brunswick
85 Charlotte Street, Suite 300
Saint John, New Brunswick E2L 2J2
Telephone: 506-658-3060
Toll free in Canada: 1 866-933-2222
Facsimile: 506-658-3059
Email: [email protected]
Public official contact regarding indirect collection of information: Chief Executive Officer and Privacy Officer
Office of the Superintendent of Securities Service Newfoundland and Labrador
P.O. Box 8700
Confederation Building
2nd Floor, West Block
Prince Philip Drive
St. John’s, Newfoundland and Labrador A1B 4J6
Attention: Superintendent of Securities
Telephone: 709-729-2571
Facsimile: 709-729-6187
Public official contact regarding indirect collection of information: Superintendent of Securities
Government of the Northwest Territories Office of the Superintendent of Securities
P.O. Box 1320
Yellowknife, Northwest Territories X1A 2L9
Telephone: 867-767-9305
Facsimile: 867 873-0243
Public official contact regarding indirect collection of information: Superintendent of Securities
Nova Scotia Securities Commission
Suite 400, 5251 Duke Street
Duke Tower
P.O. Box 458
Halifax, Nova Scotia B3J 2P8
Telephone: 902-424-7768
Facsimile: 902-424-4625
Public official contact regarding indirect collection of information: Executive Director
18
Office of the Superintendent of Securities, Nunavut
Legal Registries Division
P.O. Box 1000, Station 570
4th Floor, Building 1106
Iqaluit, Nunavut X0A 0H0
Telephone: 867-975-6590
Facsimile: 867-975-6594
Public official contact regarding indirect collection of information: Superintendent of Securities
Ontario Securities Commission
20 Queen Street West, 22nd Floor
Toronto, Ontario M5H 3S8
Telephone: 416-593-8314
Toll free in Canada: 1-877-785-1555
Facsimile: 416-593-8122
Email: [email protected]
Public official contact regarding indirect collection of information: Inquiries Officer
Prince Edward Island Securities Office
95 Rochford Street, 4th Floor Shaw Building
P.O. Box 2000
Charlottetown, Prince Edward Island C1A 7N8
Telephone: 902-368-4569
Facsimile: 902-368-5283
Public official contact regarding indirect collection of information: Superintendent of Securities
Autorité des marchés financiers
800, Square Victoria, 22e étage
C.P. 246, Place Victoria
Montréal, Québec H4Z 1G3
Telephone: 514-395-0337 or 1-877-525-0337
Facsimile: 514-873-6155 (For filing purposes only)
Facsimile: 514-864-6381 (For privacy requests only)
Email: [email protected] (For corporate finance issuers)
[email protected] (For investment fund issuers)
Public official contact regarding indirect collection of information: Corporate Secretary
Financial and Consumer Affairs Authority of Saskatchewan
Suite 601 - 1919 Saskatchewan Drive
Regina, Saskatchewan S4P 4H2
Telephone: 306-787-5842
Facsimile: 306-787-5899
Public official contact regarding indirect collection of information: Executive Director, Securities Division
Office of the Superintendent of Securities, Government of Yukon, Department of Community Services
307 Black Street, 1st Floor
P.O. Box 2703, C-6
Whitehorse, Yukon Y1A 2C6
Telephone: 867-667-5466
Facsimile: 867-393-6251
Email: [email protected]
Public official contact regarding indirect collection of information: Superintendent of Securities